MegaRobo Technologies has raised nearly $200 million in a round joined by Oman Investment Authority, the sovereign wealth fund of Oman. The Chinese company announced the funding on November 19, 2026, and did not disclose a valuation.

MegaRobo builds robots and AI software that run laboratory experiments for drug research. The round brings its total funding to about $600 million, the company said.

MegaRobo funding round and investors

CMB International joined Oman Investment Authority as a new investor. Existing backers Asia Investment Capital, Granite Asia and Sinovation Ventures also took part, Bloomberg reported.

MegaRobo did not name the stage of the round. It said the money will go toward research and development and expansion outside China.

YearRoundAmountLead or named investors
2019Growth roundNot disclosedRobert Bosch Venture Capital
2021Series B$30MNot disclosed
2022Series C$300MGoldman Sachs Asset Management, GGV Capital, Asia Investment Capital
2026New roundNearly $200MOman Investment Authority, CMB International (new)

MegaRobo disclosed funding rounds (US$ millions)

The 2022 Series C was MegaRobo’s largest round to date. Caproasia reported that the round valued the company at about $1 billion.

What MegaRobo builds for AI lab automation

Founded in 2016, MegaRobo makes robotic systems that let AI software carry out physical experiments. It also sells precision measurement and inspection tools to manufacturers, SiliconANGLE reported.

Its main product, the One Intelligence Stack, links AI models, lab instruments and robots in a closed loop. The system runs an experiment, records the result and feeds that data into the next round of analysis.

The company’s Megalaxy Lab has served more than 200 customers. Through a program called Poreva Open, the lab will support testing of more than 10,000 protein sequences, according to The AI Insider.

On factory lines, MegaRobo’s tools inspect semiconductor and display production. Finding process defects early can raise the share of usable output.

MegaRobo customers, revenue and Hong Kong IPO filing

MegaRobo serves more than 1,200 pharmaceutical firms, biotech companies and academic institutions, chief executive Daniel Huang told DealStreetAsia. About 80% of its revenue comes from China.

Huang said the company sees room to grow overseas, with a focus on Belt and Road markets.

MegaRobo filed for a Hong Kong IPO in June 2025. Its prospectus showed more than 880 customers at the end of 2024, and the top five customers made up 56.2% of revenue that year, 36Kr reported.

Huang co-founded MegaRobo with Zhixin Qiao. Earlier investors include Robert Bosch Venture Capital, Sinovation Ventures and WuXi AppTec.

AI drug discovery funding in November 2026

MegaRobo’s raise came during a week of large rounds for AI drug research. Isomorphic Labs announced a $5 billion Series C on November 17, and London-based Boltz closed a $110 million Series A led by Bessemer.

MegaRobo had the second-largest deal in our AI funding roundup for November 19, behind Payhawk.

FAQ

How much did MegaRobo raise?

MegaRobo raised nearly $200 million, announced on November 19, 2026. Oman Investment Authority and CMB International joined as new investors.

The company did not disclose its valuation.

What is MegaRobo’s total funding?

MegaRobo has raised about $600 million, according to the company. Earlier disclosed rounds include a $30 million Series B in 2021 and a $300 million Series C in 2022.

What does MegaRobo do?

MegaRobo builds robots and AI software that run laboratory experiments for drug research. It also sells inspection tools for semiconductor and display production lines.

Who founded MegaRobo?

Daniel Huang and Zhixin Qiao founded MegaRobo in 2016. Huang is chief executive.

Is MegaRobo planning an IPO?

MegaRobo filed for a Hong Kong IPO in June 2025. AI Weekly reported in November 2026 that the application was still pending.

Sheldon researches company ownership and business models for AIFundingtracker.com, covering who controls tech and AI companies and how they make money. He also writes plain-language guides to online platforms and what readers should know before using them.

Leave A Reply